Echocardiographic manifestations of mitochondrial disease with GTPBP3 gene mutations: A case report
- PMID: 38701254
- PMCID: PMC11062751
- DOI: 10.1097/MD.0000000000037847
Echocardiographic manifestations of mitochondrial disease with GTPBP3 gene mutations: A case report
Abstract
Rationale: Mitochondrial diseases are a group of disorders in which mutations in mitochondrial DNA or nuclear DNA lead to dysfunctional oxidative phosphorylation of cells, with mutations in mitochondrial DNA being the most common cause of mitochondrial disease, and mutations in nuclear genes being rarely reported. The echocardiographic findings of mitochondrial diseases with nuclear gene mutations in children's hearts are even rarer. Even more valuable is that we followed up the patient for 4 years and dynamically observed the cardiac echocardiographic manifestations of mitochondrial disease. Provide ideas for the clinical diagnosis and prognosis of mitochondrial diseases.
Patient concerns: The patient was seen in the pediatric outpatient clinic for poor strength and mental retardation. echocardiography: mild left ventricular (LV) enlargement and LV wall thickening. Nuclear genetic testing: uanosine triphosphate binding protein 3 (GTPBP3) gene mutation. Diagnosis of mitochondrial disease.
Diagnoses: Mitochondrial disease with GTPBP3 gene mutations.
Outcomes: After receiving drug treatment, the patient exhibited a reduction in lactate levels, an enhanced physical condition compared to prior assessments, and demonstrated average intellectual development.
Lessons subsections: For echocardiographic indications of LV wall thickening and LV enlargement, one needs to be alert to the possibility of hereditary cardiomyopathy, especially in children.
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Figures
Similar articles
-
Pathogenicity Analysis of a Novel Variant in GTPBP3 Causing Mitochondrial Disease and Systematic Literature Review.Genes (Basel). 2023 Feb 22;14(3):552. doi: 10.3390/genes14030552. Genes (Basel). 2023. PMID: 36980825 Free PMC article.
-
The defective expression of gtpbp3 related to tRNA modification alters the mitochondrial function and development of zebrafish.Int J Biochem Cell Biol. 2016 Aug;77(Pt A):1-9. doi: 10.1016/j.biocel.2016.05.012. Epub 2016 May 13. Int J Biochem Cell Biol. 2016. PMID: 27184967
-
Defective Expression of the Mitochondrial-tRNA Modifying Enzyme GTPBP3 Triggers AMPK-Mediated Adaptive Responses Involving Complex I Assembly Factors, Uncoupling Protein 2, and the Mitochondrial Pyruvate Carrier.PLoS One. 2015 Dec 7;10(12):e0144273. doi: 10.1371/journal.pone.0144273. eCollection 2015. PLoS One. 2015. PMID: 26642043 Free PMC article.
-
Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases.J Hum Genet. 2019 Feb;64(2):113-125. doi: 10.1038/s10038-018-0528-6. Epub 2018 Nov 21. J Hum Genet. 2019. PMID: 30459337 Review.
-
Movement disorders in mitochondrial diseases.Rev Neurol (Paris). 2016 Aug-Sep;172(8-9):524-529. doi: 10.1016/j.neurol.2016.07.003. Epub 2016 Jul 28. Rev Neurol (Paris). 2016. PMID: 27476418 Review.
References
-
- Holmgren D, Wåhlander H, Eriksson BO, et al. . Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J. 2003;24:280–8. - PubMed
-
- Scaglia F, Towbin JA, Craigen WJ, et al. . Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics. 2004;114:925–31. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical